A Study of RO6958688 in Participants With Locally Advanced and/or Metastatic Carcinoembryonic Antigen Positive Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Tocilizumab
Related studies linked through entity extraction aliases.
A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Local, Non-Interventional Study of RoActemra (Tocilizumab) in Poland (ACT-POL): First-Line Treatment in Routine Clinical Practice of Participants With Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- N/A
A Study of Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Tocilizumab for Chronic Graft-versus-Host Disease Treatment
- Status
- WITHDRAWN
- Phase
- PHASE2
Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
Tocilizumab for Renal Graft Inflammation
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis
- Status
- COMPLETED
- Phase
- PHASE3
Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- PHASE1
Uncontrolled Study to Evaluate Efficacy of Tocilizumab in Patients With Moderate or Severe Rheumatoid Arthritis
- Status
- UNKNOWN
- Phase
- PHASE4
Allogeneic or Haploidentical Stem Cell Transplant Followed By High-Dose Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
AIDS 347: IL-6 Blockade in Treated HIV Infection
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Subcutaneous (SC) Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis (RA) and Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent
- Status
- COMPLETED
- Phase
- PHASE3
Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis
- Status
- COMPLETED
- Phase
- PHASE2
Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE4
TOSCARA Study: A Study of Subcutaneous Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis Naïve to RoActemra/Actemra Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Tocilizumab and Hemophagocytic Lymphohistiocytosis (HLH)
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Tocilizumab (RoActemra) in Tocilizumab-Naive Participants With Rheumatoid Arthritis and Inadequate Response to Non-Biologic Disease-Modifying Antirheumatic Drugs (DMARDs) and/or Biologic Therapy
- Status
- COMPLETED
- Phase
- PHASE3
A Study of the Efficacy and Safety of Tocilizumab in Adults With Rheumatoid Arthritis.
- Status
- COMPLETED
- Phase
- PHASE3